← All trials
NCT03302299
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 7, 2017
- Primary completion
- Feb 26, 2021
- Completion date
- Aug 31, 2021
- First posted
- —
- Last posted
- —
- Enrollment
- 300
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of California, San FranciscoLead sponsor
- Boston UniversityCollaborator
- University of California, San FranciscoOverall official - principal investigator
- Mbarara University of Science and TechnologyCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.